Gordon T. Bolger

An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

Daniel Lamarre, Paul C. Anderson, Murray D. Bailey et al. · Nature · 2003 · 911 citations

Antiviral Effects, Hepatology, Hepatitis C Virus +9

Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.

Gordon T. Bolger, Peter J. Gengo, R Klockowski et al. · Journal of Pharmacology and Experimental Therapeutics · 1983 · 297 citations

Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease

James J. Crute, Christine A. Grygon, Karl D. Hargrave et al. · Nature Medicine · 2002 · 230 citations

Molecular Virology, Viral Persistence, Pathogenesis +7

Macrocyclic Inhibitors of the NS3 Protease as Potential Therapeutic Agents of Hepatitis C Virus Infection

Youla S. Tsantrizos, Gordon T. Bolger, Pierre Bonneau et al. · Angewandte Chemie International Edition · 2003 · 188 citations

Immunology, Nmr-derived Conformation, Antiviral Drug +17

Structure−Activity Study on a Novel Series of Macrocyclic Inhibitors of the Hepatitis C Virus NS3 Protease Leading to the Discovery of BILN 2061

Montse Llinàs‐Brunet, Murray D. Bailey, Gordon T. Bolger et al. · Journal of Medicinal Chemistry · 2004 · 186 citations

Competitive Hexapeptide Inhibitors, Pharmacotherapy, Antiviral Drug +16